Dec 2, 2025 04:31PM

Dec 2, 2025 09:17AM

Aug 4, 2025 08:40AM

Jul 14, 2025 06:00AM

Apr 4, 2025 09:01AM

Apr 1, 2025 07:30AM

Mar 26, 2025 09:05AM Sonnet BioTherapeutics (SONN) Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin

Mar 19, 2025 08:50AM

Feb 19, 2025 08:37AM

Feb 13, 2025 08:30AM

Jan 28, 2025 09:05AM

Jan 22, 2025 04:19PM

Jan 21, 2025 09:05AM

Dec 9, 2024 03:43PM Sonnet BioTherapeutics (SONN) Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Dec 9, 2024 08:45AM

Dec 4, 2024 09:20AM

Nov 6, 2024 01:20PM

Nov 6, 2024 09:25AM

Nov 6, 2024 08:32AM

Oct 28, 2024 09:07AM

Oct 17, 2024 08:45AM Sonnet BioTherapeutics (SONN) Regains Nasdaq Compliance

Oct 9, 2024 08:45AM

Oct 4, 2024 08:31AM

Sep 30, 2024 09:00AM

Sep 25, 2024 08:30AM

Aug 19, 2024 08:45AM

Jul 24, 2024 08:31AM

Jun 20, 2024 08:37AM Sonnet BioTherapeutics (SONN) Receives $3.4M From Warrants Exercise

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All